[go: up one dir, main page]

Rittenhouse et al., 1999 - Google Patents

Role of N‐and L‐type calcium channels in depolarization‐induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and …

Rittenhouse et al., 1999

Document ID
3296678131134646279
Author
Rittenhouse A
Zigmond R
Publication year
Publication venue
Journal of neurobiology

External Links

Snippet

Multiple types of voltage‐activated calcium (Ca2+) channels are present in all nerve cells examined so far; however, the underlying functional consequences of their presence is often unclear. We have examined the contribution of Ca2+ influx through N‐and L‐type voltage …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/944—Acetylcholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Similar Documents

Publication Publication Date Title
Köhr et al. Calbindin-D28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons
Georgiou et al. Synaptic regulation of glial protein expression in vivo
Grant et al. A glutamate-activated chloride current in cone-driven ON bipolar cells of the white perch retina
Mulle et al. A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques
Kume et al. Muscarinic inhibition of single KCa channels in smooth muscle cells by a pertussis-sensitive G protein
Rittenhouse et al. Role of N‐and L‐type calcium channels in depolarization‐induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals
Pacaud et al. Ca2+ channel activation and membrane depolarization mediated by Cl− channels in response to noradrenaline in vascular myocytes
US6472165B1 (en) Modulatory binding site in potassium channels for screening and finding new active ingredients
Ferrari et al. Spontaneous calcium transients regulate myofibrillogenesis in EmbryonicXenopusMyocytes
Reed et al. Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro
Uchida et al. Dopamine activates inward rectifier K+ channel in acutely dissociated rat substantia nigra neurones
Neary et al. ATP-evoked calcium signal stimulates protein phosphorylation/dephosphorylation in astrocytes
Rittenhouse et al. ω‐Conotoxin inhibits the acute activation of tyrosine hydroxylase and the stimulation of norepinephrine release by potassium depolarization of sympathetic nerve endings
Murthy et al. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C
Suneja et al. Uptake and release of D‐aspartate, GABA, and glycine in guinea pig brainstem auditory nuclei
Kirchgessner et al. Detection of the 5‐HT1A receptor and 5‐HT1A receptor mRNA in the rat bowel and pancreas: Comparison with 5‐HT1Preceptors
Failli et al. Taurine antagonizes the increase in intracellular calcium concentration induced by α-adrenergic stimulation in freshly isolated guinea-pig cardiomyocytes
Taraskevich et al. Pharmacological and ionic features of γ-aminobutyric acid receptors influencing electrical properties of melanotrophs isolated from the rat pars intermedia
Hankins et al. Early abnormalities of retinal dopamine pathways in rats with hereditary retinal dystrophy
Schoffelmeer et al. Evidence for a presynaptic adenylate cyclase system facilitating [3H] norepinephrine release from rat brain neocortex slices and synaptosomes
Vanneste et al. Inhibitory pathways in the circular muscle of rat jejunum
Ishibashi et al. Inhibition of the 5-HT1A receptor-mediated inwardly rectifying K+ current by dextromethorphan in rat dorsal raphe neurones
Mcgehee et al. Bradykinin modulates the electrophysiology of cultured rat sensory neurons through a pertussis toxin-insensitive G protein
Do Nascimento et al. Atypical effect of dopamine in modulating the functional inhibition of NMDA receptors of cultured retina cells
Marrero et al. Loose-patch clamp currents from the hypothalamo-neurohypophysial system of the rat